Holen Sie sich die Stockscreener-App
16.48
0.96%
-0.16
Handel nachbörslich:
16.48
Schlusskurs vom Vortag:
$16.64
Offen:
$16.53
24-Stunden-Volumen:
160.39K
Relative Volume:
0.97
Marktkapitalisierung:
$1.02B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.21M
KGV:
-13.51
EPS:
-1.22
Netto-Cashflow:
$-33.16M
1W Leistung:
-12.25%
1M Leistung:
-4.74%
6M Leistung:
+111.01%
1J Leistung:
+169.28%
1-Tages-Spanne:
$16.05
$17.02
1-Wochen-Bereich:
$16.05
$18.98
52-Wochen-Spanne:
$6.01
$22.69
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie PLSE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PLSE | 16.48 | 1.02B | 0 | -42.21M | -33.16M | -1.22 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder, Top Key Executive Robert Duggan sees holdings value fall by 4.8% following recent drop - Simply Wall St
When the Price of (PLSE) Talks, People Listen - Stock Traders Daily
Creative Planning Purchases 11,667 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Trading 7.6% HigherStill a Buy? - MarketBeat
Critical Analysis: Pulse Biosciences (NASDAQ:PLSE) and Spectral AI (NASDAQ:MDAI) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2024 Earnings Call Transcript - Insider Monkey
Pulse Biosciences Reports Positive Data From Benign Thyroid Study - MarketWatch
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association - Business Wire
Pulse Biosciences Appoints David Kenigsberg, M.D. As Chief Medical Officer Of Electrophysiology - citybiz
Pulse Biosciences (NASDAQ:PLSE) Announces Earnings Results - MarketBeat
Pulse Biosciences Inc Reports Q3 2024 GAAP Net Loss of $12.7 Mil - GuruFocus.com
Pulse Biosciences (NASDAQ:PLSE) Shares Pass Below 50-Day Moving AverageWhat's Next? - MarketBeat
Pulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Pulse Biosciences Reports Q3 2024 Financials and Developments - TipRanks
Pulse Biosciences appoints new electrophysiology CMO - Investing.com
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results - The Bakersfield Californian
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology - Business Wire
(PLSE) Trading Report - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 7.4%What's Next? - MarketBeat
Pulse Biosciences (PLSE) Scheduled to Post Earnings on Wednesday - MarketBeat
Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024 - StockTitan
Pulse Biosciences (NASDAQ:PLSE) Stock Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat
(PLSE) On The My Stocks Page - Stock Traders Daily
Renaissance Technologies LLC Lowers Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Cross Below 50 Day Moving AverageShould You Sell? - MarketBeat
PLSE MONDAY DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 18 Deadline in Securities Class ActionPLSE - AsiaOne
Long Term Trading Analysis for (PLSE) - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $17.54 - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Shares Down 5% - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 5% - Defense World
Bank of New York Mellon Corp Buys 9,639 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.4% - MarketBeat
Pulse Biosciences Inc [PLSE] Investment Appeal on the Rise - Knox Daily
How To Trade (PLSE) - Stock Traders Daily
Metric Deep Dive: Understanding Pulse Biosciences Inc (PLSE) Through its Ratios - The Dwinnex
Inspire Investing LLC Sells 8,725 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to "Sell" - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Upgraded to “Sell” at StockNews.com - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - Defense World
Quest Partners LLC Purchases New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - Defense World
Keeping an Eye on Pulse Biosciences Inc (PLSE) After Insider Trading Activity - Knox Daily
Pulse Biosciences (NASDAQ:PLSE) Trading Up 7% - MarketBeat
Paul LaViolette Joins Pulse Bioscience's Board Of Directors - MPO-mag
Paul LaViolette Joins Pulse Bioscience’s Board of Directors - MPO-mag
Pulse Biosciences (NASDAQ:PLSE) Trading Down 9.6% - MarketBeat
Pulse Biosciences Inc (PLSE) may enjoy gains as insiders got busy in the recent days - Knox Daily
Ratios in Focus: Analyzing Pulse Biosciences Inc (PLSE)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Pulse Biosciences Inc [PLSE] Investment Guide: What You Need to Know - Knox Daily
(PLSE) Technical Data - Stock Traders Daily
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):